Withings' Body Scan 2 smart scale is now available for purchase in the US at $600, following its European launch in June and a delay caused by FDA regulatory review Engadget. The device was announced at CES in January with an expected second-quarter 2026 release date, but US availability came later than planned MacRumors. The price is higher than equivalent pricing in Europe — it costs €499.95 in the EU and £449.95 in the UK, a pattern typical of Withings' US pricing for connected health devices Gadgets & Wearables, Withings UK press release.

What the Device Actually Does

The core pitch is that Body Scan 2 delivers body-composition measurements rivaling a DEXA scan, the clinical gold standard that normally requires a specialized imaging facility Engadget. It measures 60 different biomarkers — up from 40 on the original Body Scan — and Withings says the full measurement panel takes 90 seconds Withings US landing page. That figure comes from the company's own specifications rather than independent testing.

The scale uses two measurement techniques working together. Bioimpedance Spectroscopy (BIS) sends small electrical currents at 13 different frequencies through electrodes in a retractable handle and the glass plate. This tells you things like total body water, cellular age, active muscle mass, and metabolic rate. Impedance Cardiography (ICG), which is new to this version, measures how effectively your heart pumps blood to your organs Withings UK press release, Engadget. Together, these feed into a feature called "Health Trajectory" — a predictive model that Withings is positioning as the device's main selling point Withings US landing page.

Two of the device's health features required FDA clearance before it could legally be sold in the US: alerts for hypertension risk and a six-lead EKG function that detects irregular heart rhythms like atrial fibrillation The Verge. Withings has secured those approvals, and both features are active Engadget. A third feature, a Diabetes Risk Score, is still pending FDA review and won't be available to US users until cleared, even though it shipped with the UK version Withings UK press release.

Recent firmware updates introduced two distinct measurement modes: Longevity Scan, for deeper analysis, and Daily Scan, for quick check-ins, along with blood oxygen readings Withings support article. Withings hasn't specified how these modes differ in terms of which sensors activate or which biomarkers they each include.

One practical note: as of this writing, Withings' official US product pages still show "Available soon" badges and disclaimers stating the device is "not currently available for sale or distribution" Withings US landing page. This may reflect a staged rollout, a website that hasn't been updated yet, or regional restrictions within Withings' sales system. If you're trying to order directly from Withings rather than through a retail partner, this discrepancy is worth checking.

The Bigger Picture: Premium Health Monitoring Becomes a Trend

Withings is marketing Body Scan 2 as "the first science-backed longevity station," a phrase aimed squarely at a growing consumer category focused on preventive health monitoring. The device is endorsed by Dr. Platzer, a physician specializing in preventive and longevity medicine, and Withings is positioning it for people managing chronic stress, sedentary routines, midlife weight gain, perimenopause and menopause, athletic training, and even those taking GLP-1 weight-loss medications Withings US landing page. This product sits in a space increasingly crowded with companies like Apple and Oura, all competing to turn occasional clinical-style testing into a routine users repeat regularly — and ideally, pay ongoing subscription fees for.

The $600 price is just the start. Body Scan 2 comes with one month free access to Withings+, the company's premium subscription for continuous health monitoring and trend analysis Engadget. Withings hasn't published what Withings+ costs after the trial ends, so anyone considering this device can't easily calculate the true cost of ownership compared to traditional options like periodic DEXA scans.

The real question for devices like this isn't whether a single measurement is accurate. It's whether collecting data week after week — watching trends rather than snapshots — actually changes how people make health decisions. A DEXA scan freezes your body composition at one moment in time. A scale you step on daily or weekly builds a long-term picture of change. Whether that ongoing data stream leads to real behavioral shifts, or simply becomes another app people check once and forget, will determine whether the "longevity station" category turns into lasting technology or a temporary marketing phenomenon.